Community submitted · NIH Common Fund97 days left
Targeting RNA in Disease with Novel Technologies (TRDNT) — Phase II Stage I
Prototype-development and use-case demonstration for technologies targeting RNA in disease. Award: Up to $4,800,000 for Phase II Stage I.
Eligibility
Phase II Stage I is open to eligible participants under official rules.
Eligible for
Postdoc / Faculty / Independent researcher / Industry
Deadline
2/1/2027